|
MEAF6 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62436730732907E-12 |
| Normal-vs-Stage2 |
2.199900E-04 |
| Normal-vs-Stage3 |
2.76667577736589E-12 |
| Normal-vs-Stage4 |
1.41109346429857E-12 |
| Stage1-vs-Stage2 |
7.305600E-02 |
| Stage1-vs-Stage3 |
2.978400E-01 |
| Stage1-vs-Stage4 |
6.453200E-01 |
| Stage2-vs-Stage3 |
3.037000E-01 |
| Stage2-vs-Stage4 |
5.653600E-02 |
| Stage3-vs-Stage4 |
2.288000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62436730732907E-12 |
| Normal-vs-AfricanAmerican |
1.352170E-04 |
| Normal-vs-Asian |
2.99710034568079E-10 |
| Caucasian-vs-AfricanAmerican |
4.308000E-01 |
| Caucasian-vs-Asian |
2.627600E-01 |
| AfricanAmerican-vs-Asian |
9.755400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.66044955562938E-12 |
| Normal-vs-Female |
1.62436730732907E-12 |
| Male-vs-Female |
2.308600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
<1E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.5340000047992E-08 |
| Normal-vs-Age(81-100Yrs) |
1.955450E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.617000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.299800E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.286400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.383600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.269200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.801000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.323200E-01 |
| Classical-VS-Follicular |
9.02209995601311E-09 |
| Classical-VS-Other |
5.800000E-01 |
| Classical-VS-Normal |
<1E-12 |
| Tall-VS-Follicular |
2.361200E-04 |
| Tall-VS-Other |
7.903400E-01 |
| Tall-VS-Normal |
5.31729993369368E-10 |
| Follicular-VS-Other |
2.074400E-01 |
| Follicular-VS-Normal |
1.439840E-03 |
| Other-VS-Normal |
1.089570E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.70041758451589E-12 |
| Normal-vs-N1 |
3.96610000397146E-09 |
| N0-vs-N1 |
4.122800E-01 |
|
|
